Activin Receptor Type 2: Unraveling Its Role in Cellular Processes

Target Name: Activin receptor type 2 (nonspecifed subtype)

NCBI ID: P38453

Activin receptor type 2 (nonspecifed subtype)

Other Name(s): Activin receptor type II | ACVR2 | Activin receptor type 2

Activin Receptor Type 2: Unraveling Its Role in Cellular Processes

Activin receptor type 2 (Activin receptor type II), also known as activin receptor alpha chain (AR伪), is a protein that plays a crucial role in various cellular processes in the body. It is a member of the activin receptor family, which consists of four subtypes, including Activin receptor type 1 (Activin receptor type I), Activin receptor type 2 (Activin receptor type II), Activin receptor type 3 (Activin receptor type III), and Activin receptor type 4 (Activin receptor type IV).

Activin receptor type 2 is a protein that is expressed in various tissues throughout the body, including the liver, spleen, kidney, and pancreas. It is primarily localized to the cytoplasm of cells and is involved in the regulation of cellular processes such as cell growth, differentiation, and survival.

One of the most significant functions of Activin receptor type 2 is its role in the regulation of cell growth and differentiation. Activin receptor type 2 has been shown to play a negative role in the regulation of cell growth by inhibiting the activity of the oncogene transforming growth factor beta (TGF-β). TGF-β is a protein that promotes cell growth and has been linked to various diseases, including cancer, cardiovascular disease, and neurodegenerative diseases.

Activin receptor type 2 has also been shown to play a role in the regulation of cell differentiation. It has been shown to be involved in the regulation of stem cell proliferation and the differentiation of stem cells into functional tissues such as muscle, heart, and brain cells.

In addition to its role in cell growth and differentiation, Activin receptor type 2 has also been shown to play a role in the regulation of cellular survival. It has been shown to play a negative role in the regulation of cell survival by inhibiting the activity of the pro-inflammatory protein, nuclear factor kappa B (NF-kappa-B). NF-kappa-B is a protein that plays a role in the regulation of inflammation and has been linked to various diseases, including cancer and neurodegenerative diseases.

Activin receptor type 2 has also been shown to play a role in the regulation of cellular signaling pathways. It is a component of several signaling pathways, including the TGF-β signaling pathway, the Wnt signaling pathway, and the Hedgehog signaling pathway. These signaling pathways are involved in the regulation of various cellular processes, including cell growth, differentiation, and survival.

Despite its widespread involvement in cellular processes, Activin receptor type 2 is not yet a well-studied protein. There are only a few studies that have investigated its function in various cellular processes, and more research is needed to fully understand its role in these processes.

In conclusion, Activin receptor type 2 is a protein that plays a crucial role in various cellular processes in the body. It is involved in the regulation of cell growth, differentiation, and survival, and has been shown to play a negative role in the regulation of these processes by inhibiting the activity of TGF-β and NF-kappa-B. Given its widespread involvement in cellular processes, Activin receptor type 2 is a potential drug target or biomarker for various diseases. Further research is needed to fully understand its role in these processes and to develop new treatments for these diseases.

Protein Name: Activin Receptor Type 2 (nonspecifed Subtype)

The "Activin receptor type 2 (nonspecifed subtype) Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Activin receptor type 2 (nonspecifed subtype) comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets